Robotic Apparel to Prevent Freezing of Gait in Parkinson Disease (NCT06602544)
Preventing Freezing of Gait in Parkinson's Disease Using Soft Robotic Apparel
๐ฉบ Plain-English Summary (8th-Grade Level)
Freezing-of-gait (FoG) in Parkinson Disease (PD) is one of the most vivid and disturbing gait phenomena in neurology. Often described by patients as a feeling of "feet getting glued to the floor," FoG is formally defined as a "brief, episodic absence or marked reduction of forward progression of the feet despite the intention to walk." This debilitating gait phenomena is very common in PD, occurring in up to 80% of individuals with severe PD. When FoG arrests walking, serious consequences can occur such as loss of balance, falls, injurious events, consequent fear of falling, and increased hospitalization. Wearable robots are capable of augmenting spatiotemporal gait mechanics and are emerging as viable solutions for locomotor assistance in various neurological populations. For the proposed study, our goal is to understand how low force mechanical assistance from soft robotic apparel can best mitigate gait decline preceding a freezing episode and subsequent onset of FoG by improving spatial (e.g. stride length) and temporal features (e.g. stride time variability) of walking. We hypothesize that the ongoing gait-preserving effects can essentially minimize the accumulation of motor errors that lead to FoG. Importantly, the autonomous assistance provided by the wearable robot circumvents the need for cognitive or attentional resources, thereby minimizing risks for overloading the cognitive systems -- a known trigger for FoG, thus enhancing the repeatability and robustness of FoG-preventing effects.
Who can join: Review the eligibility criteria below.
Location: Harvard Science and Engineering Complex โ Allston, Massachusetts
Age range: 18 Years to 90 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (2 Sites)
- Harvard Science and Engineering Complex โ Allston, Massachusetts
- Boston University Sargent College of Health and Rehabilitation Sciences โ Boston, Massachusetts
๐ Contact the Study Coordinator
Phone: (617) 353-7525
Email: fporciun@bu.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Parkinson Disease (PD)
- Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson Disease โ Philadelphia, Pennsylvania
- Behavioral Intervention for Lifestyle Physical Activity in Parkinson's Disease โ Chicago, Illinois
- Passive Versus Active Music Therapy Parkinson's Disease โ Birmingham, Alabama
- 18F-mFBG Cardiac Uptake With Lewy Body Dementia โ Houston, Texas
- GBPDC: Gut-Brain in PD Consortium Master Protocol โ Stanford, California
Explore by condition: All Parkinson Disease (PD) clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.